Veradermics Files S-1MEF for Additional Securities

Ticker: MANE · Form: S-1MEF · Filed: Apr 30, 2026 · CIK: 0001827635

Veradermics, Inc S-1MEF Filing Summary
FieldDetail
CompanyVeradermics, Inc (MANE)
Form TypeS-1MEF
Filed DateApr 30, 2026
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: registration-statement, securities-offering, pharmaceuticals

TL;DR

Veradermics just filed to add more shares to their offering. Watch for potential dilution.

AI Summary

Veradermics, Inc. filed an S-1MEF on April 29, 2026, to register additional securities under a prior Form S-1 registration. The filing indicates an effectiveness date of April 29, 2026. The company is involved in the pharmaceutical preparations industry, with its mailing and business address at 470 James Street, New Haven, CT 06513.

Why It Matters

This filing allows Veradermics to potentially issue more shares, which could impact its stock price and ownership structure.

Risk Assessment

Risk Level: medium — S-1MEF filings often precede additional share offerings, which can lead to dilution and price volatility.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of an S-1MEF filing?

An S-1MEF filing, under Rule 462(b), is used to register additional securities when a company has a pending registration statement on Form S-1.

When was this S-1MEF filing accepted by the SEC?

The S-1MEF filing was accepted on April 29, 2026, at 21:44:57.

What is Veradermics, Inc.'s CIK number?

Veradermics, Inc.'s CIK number is 0001827635.

What industry is Veradermics, Inc. primarily involved in?

Veradermics, Inc. is primarily involved in Pharmaceutical Preparations (SIC code 2834).

What is the business address of Veradermics, Inc.?

The business address of Veradermics, Inc. is 470 James Street, New Haven, CT 06513.

Filing Details

This Form S-1MEF (Form S-1MEF) was filed with the SEC on April 30, 2026 regarding Veradermics, Inc (MANE).

View full filing on EDGAR

View Full Filing

View this S-1MEF filing on SEC EDGAR

View on Read The Filing